Eurofins, FR0014000MR3

Goldman Sachs raises target for Eurofins stock to EUR 89

Published on 10/26/2026 at 15:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Revenue reached EUR 5.614 billion in nine months of 2026. Eurofins stock costs EUR 86.23 on October 26, 2026, up 2.10 percent versus Tradegate close.

Analyst target and reporting date

  • Goldman Sachs raised its 12-month target for Eurofins on October 6, 2026.
  • Nine-month revenue reached EUR 5.614 billion in 2026.
  • Eurofins stock costs EUR 86.23 at Lang & Schwarz on October 26, 2026, 2.10 percent above the Tradegate close of October 23, 2026.
  • Eurofins plans an investor day in Toronto on November 11, 2026.
Eurofins, FR0014000MR3, Illustration mit AI erstellt.

Goldman Sachs raised its 12-month price target for Eurofins from EUR 85.00 to EUR 89.00 on October 6, 2026, while reiterating its Buy rating. The target stands 3.21 percent above the Lang & Schwarz price of EUR 86.23 on October 26, 2026 at 3:37 p.m. CEST, which was 2.10 percent above the Tradegate close of October 23, 2026 at EUR 84.46.

Revenue growth reaches 3.70 percent

Eurofins reported revenue of EUR 5.614 billion for the first nine months of 2026, up 3.70 percent from EUR 5.415 billion in the same period of 2025, according to Borsa Italiana. Organic revenue growth was 3.00 percent, while third-quarter organic growth accelerated to 3.50 percent.

The operating picture remains mixed across regions. In the first nine months, organic growth reached 1.90 percent in Europe, 2.80 percent in North America and 9.30 percent in the rest of the world, according to MarketScreener.

What does the target imply?

The Goldman Sachs target of EUR 89.00 is 3.21 percent above EUR 86.23. Its October 6, 2026 research also cited a 2.80 percent organic-growth forecast for the third quarter, but that estimate was below the reported 3.50 percent outcome. The report therefore gives investors a current valuation marker while the latest operating data show sequential improvement.

Investor dates and valuation

Eurofins will hold an investor day in Toronto on November 11, 2026, after its Amersfoort event on October 23, 2026, according to the company investor-relations page. The company targets an adjusted EBITDA margin of 24.00 percent for fiscal year 2027, compared with 22.50 percent in fiscal year 2025.

Eurofins had a market capitalization of EUR 14.9 billion and a price-to-earnings ratio of 29.96 as of October 26, 2026. Its 52-week range was EUR 54.86 to EUR 86.24, putting the Lang & Schwarz price 0.01 percent below the high. The stock was up 35.40 percent year to date.

Price and investor perspective

The combination of a EUR 89.00 Goldman Sachs target, nine-month revenue growth of 3.70 percent and a 24.00 percent 2027 margin objective gives the stock three distinct valuation anchors. The immediate price is near the upper end of its 52-week range, while the latest quarterly growth rate of 3.50 percent exceeded the nine-month organic rate of 3.00 percent.

Eurofins was trading at EUR 86.23 at Lang & Schwarz on October 26, 2026 at 3:37 p.m. CEST, up 2.10 percent versus the Tradegate close of October 23, 2026 at EUR 84.46. The further course of trading is shown by the continuously updated real-time quote of Eurofins stock.

Eurofins stock at a glance

  • Company: Eurofins Scientific SE
  • ISIN: FR0014000MR3
  • Ticker: ERF
  • Primary exchange: Euronext Paris
  • Price Lang & Schwarz (as of October 26, 2026, 3:37 p.m. CEST): EUR 86.23
  • Change versus Tradegate close: plus 2.10 percent
  • Tradegate close (October 23, 2026): EUR 84.46
  • Market capitalization: EUR 14.9 billion (as of October 26, 2026)
  • 52-week range: EUR 54.86-EUR 86.24 (as of October 26, 2026)
  • Sector / Industry: Healthcare / Medical Diagnostics and Research
  • Index membership: CAC 40

Market context: Market report CAC 40.

More news and analyses on Eurofins stock

Disclaimer...
en | FR0014000MR3 | EUROFINS | boerse | 70415129 |